These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19748054)

  • 1. Effect of oral curcumin on Déjérine-Sottas disease.
    Burns J; Joseph PD; Rose KJ; Ryan MM; Ouvrier RA
    Pediatr Neurol; 2009 Oct; 41(4):305-8. PubMed ID: 19748054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dejerine-Sottas' neuropathy caused by the missense mutation PMP22 Ser72Leu.
    Marques W; Neto JM; Barreira AA
    Acta Neurol Scand; 2004 Sep; 110(3):196-9. PubMed ID: 15285778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy.
    Khajavi M; Shiga K; Wiszniewski W; He F; Shaw CA; Yan J; Wensel TG; Snipes GJ; Lupski JR
    Am J Hum Genet; 2007 Sep; 81(3):438-53. PubMed ID: 17701891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dejerine-Sottas syndrome and vestibular loss due to a point mutation in the PMP22 gene.
    Jen J; Baloh RH; Ishiyama A; Baloh RW
    J Neurol Sci; 2005 Oct; 237(1-2):21-4. PubMed ID: 15992829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The range of chronic demyelinating neuropathy of infancy: a clinico-pathological and genetic study of 15 unrelated cases.
    Planté-Bordeneuve V; Parman Y; Guiochon-Mantel A; Alj Y; Deymeer F; Serdaroglu P; Eraksoy M; Said G
    J Neurol; 2001 Sep; 248(9):795-803. PubMed ID: 11596785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease.
    Parman Y; Planté-Bordeneuve V; Guiochon-Mantel A; Eraksoy M; Said G
    Ann Neurol; 1999 Apr; 45(4):518-22. PubMed ID: 10211478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dejerine-sottas disease with a novel de novo dominant mutation, Ser 149 Arg, of the peripheral myelin protein 22.
    Ohnishi A; Yamamoto T; Izawa K; Yamamori S; Takahashi K; Mega H; Jinnai K
    Acta Neuropathol; 2000 Mar; 99(3):327-30. PubMed ID: 10663978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dejerine-Sottas disease and hereditary demyelinating polyneuropathy of infancy.
    Plante-Bordeneuve V; Said G
    Muscle Nerve; 2002 Nov; 26(5):608-21. PubMed ID: 12402282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene.
    Ionasescu VV; Searby C; Greenberg SA
    J Med Genet; 1996 Dec; 33(12):1048-9. PubMed ID: 9004143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dejerine-Sottas neuropathy and PMP22 point mutations: a new base pair substitution and a possible "hot spot" on Ser72.
    Marques W; Thomas PK; Sweeney MG; Carr L; Wood NW
    Ann Neurol; 1998 May; 43(5):680-3. PubMed ID: 9585367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mutation of the MPZ gene in a family with the Dejerine-Sottas disease phenotype.
    Floroskufi P; Panas M; Karadima G; Vassilopoulos D
    Muscle Nerve; 2007 May; 35(5):667-9. PubMed ID: 17143884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.
    Sharma RA; Euden SA; Platton SL; Cooke DN; Shafayat A; Hewitt HR; Marczylo TH; Morgan B; Hemingway D; Plummer SM; Pirmohamed M; Gescher AJ; Steward WP
    Clin Cancer Res; 2004 Oct; 10(20):6847-54. PubMed ID: 15501961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile-onset of Dejerine-Sottas disease in a Taiwanese woman.
    Liao YS; Chen ST; Tang LM; Ro LS
    J Formos Med Assoc; 1996 Apr; 95(4):329-32. PubMed ID: 8935304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dejerine-Sottas syndrome grown to maturity: overview of genetic and morphological heterogeneity and follow-up of 25 patients.
    Gabreëls-Festen A
    J Anat; 2002 Apr; 200(4):341-56. PubMed ID: 12090401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene.
    Ionasescu VV; Ionasescu R; Searby C; Neahring R
    Neurology; 1995 Sep; 45(9):1766-7. PubMed ID: 7675244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uroprotective effects of curcumin in cyclophosphamide-induced haemorrhagic cystitis paradigm.
    Arafa HM
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):393-9. PubMed ID: 19413659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
    Aggarwal BB; Sung B
    Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Dejerine-Sottas disease with respiratory failure and dysmorphic features in association with a PMP22 point mutation and a 3q23 microdeletion.
    Voermans NC; Kleefstra T; Gabreëls-Festen AA; Faas BH; Kamsteeg EJ; Houlden H; Laurá M; Polke JM; Pandraud A; van Ruissen F; van Engelen BG; Reilly MM
    J Peripher Nerv Syst; 2012 Jun; 17(2):223-5. PubMed ID: 22734911
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of progressive hypertrophic neuropathy in childhood with facial diplegia (Dejerine-Sottas disease).
    Sunwoo IN; Kim JS; Chi JG; Suh YL
    Yonsei Med J; 1988; 29(3):278-85. PubMed ID: 3195160
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of curcumin therapy against Angiostrongylus cantonensis-induced eosinophilic meningitis.
    Shih PC; Lee HH; Lai SC; Chen KM; Jiang ST; Chen YF; Shiow SJ
    J Helminthol; 2007 Mar; 81(1):1-5. PubMed ID: 17381860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.